Combining Varenicline and Bupropion for Smoking Cessation
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is learn if the combination of Chantix (varenicline)
and Zyban (bupropion) is more effective at helping people to quit smoking than varenicline
when given alone. Researchers also want to learn if this drug combination can reduce cravings
and other negative symptoms of nicotine withdrawal better than varenicline does alone. The
safety of this drug combination will also be tested.
Phase:
Phase 3
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH) Pfizer